Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

100 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Active, not recruiting

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

NCT03165734

Conditions
Anemia, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • University of Alabama at Birmingham, (UAB) Hospital, Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 207 locations
View Trial Details
Active, not recruiting

A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)

NCT04446650

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Local Institution - 021 Suwa, Nagano, Japan
  • Local Institution - 001 Bunkyo-ku, Tokyo, Japan
  • Local Institution - 006 Chūō, Yamanashi, Japan
  • Local Institution - 002 Aomori, Japan
View all 21 locations
View Trial Details
Completed

Myeloproliferative Neoplasms: an In-depth Case-control Study

NCT01831635

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • University Hospitals Southampton NHS Foundation Trust Southampton, England, United Kingdom
  • Belfast Health And Social Care Trust Belfast, Northern Ireland, United Kingdom
  • Queen's University Belfast Belfast, Northern Ireland, United Kingdom
View Trial Details
Completed

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

NCT02158858

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Disease, +23 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Northwestern University - Lurie Comprehensive Cancer Center Chicago, Illinois, United States
View all 48 locations
View Trial Details
Completed

Fedratinib in Combination With Nivolumab

NCT05393674

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
  • University Medicine Greifswald Greifswald, Germany
  • Universitätsklinikum Halle (Saale) Halle, Germany
  • Medizinische Hochschule Hanover, Germany
View Trial Details

Related conditions